Week in Review: Grail Plans $500 Million Hong Kong IPO for Cancer Diagnostics

Grail, a US spinout from Illumina (NSDQ: ILMN) that is developing blood-based cancer detection tests, is considering a $500 million Hong Kong IPO (see story). Last year, Grail completed a $900 million Series B fundraising, the largest ever. In June, Grail …
( read original story …)


Related Post

World’s biggest AI startup exploring cars, expansi...
views 18
HONG KONG: SenseTime Group, the world’s most valua...
BOC Hong Kong : BOCHK awarded the Best Retail Bank...
views 24
Bank of China (Hong Kong) ("BOCHK") is awarded the...
Hong Kong Defends Its Position As a Leading Financ...
views 24
Virtual banking and open data might sound like mer...
Hong Kong Airlines debuts Chris Cosentino’s ...
views 32
HONG KONG, March 22, 2019 /CNW/ -- Hong Kong Airli...
United States warns China meddling in Hong Kong hu...
views 28
HONG KONG (Reuters) - The United States warned in ...
Restrictions on Hong Kong’s freedoms denting...
views 23
Growing restrictions on Hong Kong's freedoms are h...
After a Dip, Hong Kong Real Estate Again Eyes the ...
views 26
HONG KONG — Something strange happened recently in...
U.S. warns China meddling in Hong Kong hurting bus...
views 32
HONG KONG (Reuters) - The United States warned in ...
Hong Kong To Build $79 Billion Artificial Island T...
views 36
Hong Kong plans to build one of the world's larges...
Carrie Lam assures Hong Kong business leaders that...
views 66
Hong Kong’s leader on Thursday assured members of ...